Patents by Inventor Robert Porter

Robert Porter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Imidazopyrimidine Derivatives As Modulators of TNF Activity
    Publication number: 20160297827
    Abstract: A series of substituted imidazo[1,2-a]pyrimidine derivatives of formula (I), being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.
    Type: Application
    Filed: December 8, 2014
    Publication date: October 13, 2016
    Inventors: Mezher Hussein Ali, Daniel Christopher Brookings, Julien Alistair Brown, Victoria Elizabeth Jackson, Boris Kroeplien, John Robert Porter
  • Fused Imidazole and Pyrazole Derivatives As Modulators of TNF Activity
    Publication number: 20160297837
    Abstract: A series of substituted benzimidazole, imidazo[1,2-a]pyridine and pyrazolo[1,5-a]pyridine derivatives, and analogues thereof, being potent modulators of human TNF? activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.
    Type: Application
    Filed: December 8, 2014
    Publication date: October 13, 2016
    Inventors: Rikki Peter Alexander, Jonathan Mark Bentley, Gareth Neil Brace, Daniel Christopher Brookings, Praful Tulshi Chovatia, Hervé Jean Claude Deboves, Craig Johnstone, Elizabeth Pearl Jones, Boris Kroeplien, Fabien Claude Lecomte, James Madden, Craig Miller, John Robert Porter, Matthew Duncan Selby, Michael Alan Shaw, Darshan Gunvant Vaidya, Ian Andrew Yule
  • Tetrahydroimidazopyridine Derivatives as Modulators of TNF Activity
    Publication number: 20160289228
    Abstract: A series of substituted 5,6,7,8-tetrahydroimidazo[1,2-?]pyridine derivatives, being potent modulators of human TNF? activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.
    Type: Application
    Filed: December 8, 2014
    Publication date: October 6, 2016
    Inventors: Sabine Defays, Jag Paul Heer, Victoria Elizabeth Jackson, James Andrew Johnson, Boris Kroeplien, John Robert Porter
  • Method For Sharing A Media Collection In A Network Environment
    Publication number: 20160205113
    Abstract: In one aspect, the present disclosure provides for the accessing and playing of media files having differing associated rights such as non-DRM media files, purchased and downloaded media files, subscription download files such as tethered downloads, and subscription streamed DRM files. In one embodiment, the present disclosure provides a method and user interface for sharing a media collection among computing devices in communication via a network. In one embodiment, the disclosed method allows access and playback, from each computing device on a network, of all media files in a media collection, regardless of their associated rights.
    Type: Application
    Filed: March 18, 2016
    Publication date: July 14, 2016
    Inventors: Ryan Eric King, David E. Brown, Robert Porter, Adam Korman, Manish Upendran, Kathleen Wilson
  • Device, system and method for aggregating networks and serving data from those networks to computers
    Patent number: 9387813
    Abstract: Disclosed herein, in one example, is a device for aggregating networks in a vehicle and serving data, including video data, from those networks to a computer for integrating information from various systems in a vehicle, processing that information, and presenting the information to a user in a suitable format. The device for aggregating networks, in another example, is specific to a vehicle and serving data, including video data, from those networks to computers.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: July 12, 2016
    Assignee: Road-IQ, LLC
    Inventors: Mark M. Moeller, Lester Meeks, Rory N. McLeod, Collin J. Topolski, Ilko Dossev, Peter John Whitehead, Jeffery Robert Porter
  • SYSTEM AND METHOD FOR OPERATING A DIESEL ENGINE
    Publication number: 20160186675
    Abstract: A power generating set includes an engine operable in response to a flow of fuel to produce a flow of exhaust gas, a generator coupled to the engine and operable in response to operation of the engine to produce a total electrical power, and a primary load electrically connected to the generator to receive a portion of the total electrical power, the primary load having a cyclical pattern. A battery bank is selectively connected to the generator to receive a portion of the total electrical power and an insulated-gate bipolar transistor (IGBT) is positioned to selectively transition between a connected state and a disconnected state. The battery bank is connected to the generator to charge the battery bank when the IGBT is in the connected state and is disconnected from the generator when the IGBT is in the disconnected state.
    Type: Application
    Filed: March 9, 2016
    Publication date: June 30, 2016
    Inventors: John Thomas Gunn, Robert Porter Edwards, Barry Eugene Reavis
  • Imidazopyridine derivatives as modulators of TNF activity
    Patent number: 9309243
    Abstract: A series of imidazo[1,2-a]pyridine derivatives of formula (I), being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.
    Type: Grant
    Filed: July 5, 2013
    Date of Patent: April 12, 2016
    Assignee: UCB Biopharma SPRL
    Inventors: Jonathan Mark Bentley, Daniel Christopher Brookings, Julien Alistair Brown, Thomas Paul Cain, Praful Tulshi Chovatia, Anne Marie Foley, Ellen Olivia Gallimore, Laura Jane Gleave, Alexander Heifetz, Helen Tracey Horsley, Martin Clive Hutchings, Victoria Elizabeth Jackson, James Andrew Johnson, Craig Johnstone, Boris Kroeplien, Fabien Claude Lecomte, Deborah Leigh, Martin Alexander Lowe, James Madden, John Robert Porter, Joanna Rachel Quincey, Laura Claire Reed, James Thomas Reuberson, Anthony John Richardson, Sarah Emily Richardson, Matthew Duncan Selby, Michael Alan Shaw, Zhaoning Zhu
  • System and method for operating a diesel engine
    Patent number: 9308910
    Abstract: A power generating set includes an engine operable in response to a flow of fuel to produce a flow of exhaust gas. A generator is coupled to the engine and is operable in response to operation of the engine to produce a total electrical power, a primary load is electrically connected to the generator to receive a portion of the total electrical power, and a secondary load is selectively connected to the generator to receive a portion of the total electrical power. An insulated-gate bipolar transistor (IGBT) is positioned to selectively transition between a connected state and a disconnected state. The secondary load is connected to the generator when the IGBT is in the connected state and is disconnected from the generator when the IGBT is in the disconnected state.
    Type: Grant
    Filed: May 2, 2014
    Date of Patent: April 12, 2016
    Assignee: CLARK EQUIPMENT COMPANY
    Inventors: John Thomas Gunn, Robert Porter Edwards, Barry Eugene Reavis
  • COMPLETION TOOL LOCATING ARRANGEMENT AND METHOD OF POSITIONING A TOOL WITHIN A COMPLETION STRUCTURE
    Publication number: 20150322751
    Abstract: A completion tool locating arrangement includes, an anchor attachable within a completion structure having a bore extending through the anchor, a seat disposed at the anchor receptive to a plug runnable thereagainst, and an attachment feature positioned at the anchor.
    Type: Application
    Filed: May 8, 2014
    Publication date: November 12, 2015
    Applicant: Baker Hughes Incorporated
    Inventor: Robert A. Porter
  • Test Device and Sample Carrier
    Publication number: 20150298118
    Abstract: A test device (80) for testing for the presence of a substance in a sample held on a sample carrier (30) includes a holder (82) for holding a sample carrier (30) which includes one or more chambers (50,52). The test device (80) also includes an actuator for compressing or depressurising the chamber(s) (50,52). The actuator is configured to prevent reinflation of the chamber(s) (50,52) after compression or depressurisation.
    Type: Application
    Filed: September 27, 2013
    Publication date: October 22, 2015
    Inventors: Michael Chard, Robert Porter, Courtney Nicholson, Andrew Lakey, Simon Attree, Philip Walsh, Philip Potter, Craig Wightman, Paul Dyckes, Holger Becker, Rene Stewart, Wolfgang Engelhart, Claudia Gaertner
  • MULTI-MODAL WOUND TREATMENT APPARATUS
    Publication number: 20150290364
    Abstract: The wound treatment apparatus combines an internal negative pressure (vacuum) pump and an internal positive pressure (compressor) pump connectable to an external oxygen supply for providing both negative pressure wound therapy and hyperbaric oxygen wound therapy to a wound site. The apparatus also includes a user interface operatively connected to an electronic controller that monitors and actuates the vacuum and compressor pumps. The user interface and controller enables the apparatus to provide multiple modes of operation and the ability to selectively change between negative pressure therapy operational modes and hyperbaric oxygen operational modes.
    Type: Application
    Filed: February 13, 2013
    Publication date: October 15, 2015
    Inventors: Billy Wall, Stephen Galbraith, Robert Porter
  • Compounds for inhibiting the interaction of BCL2 with binding partners
    Patent number: 9126979
    Abstract: The present invention relates to compounds of formula I: in which R1, R2, R3 and R4 are as defined in the Summary of the Invention. Compounds of formula I are capable of disrupting the BCL-2 interations with proteins containing a BH3 domain. Disrupting this interaction can restore the anti-apoptotic function of BCL-2 in cancer cells and tumor tissue expressing BCL-2. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds in the treatment of cancerous diseases.
    Type: Grant
    Filed: December 12, 2012
    Date of Patent: September 8, 2015
    Assignee: Novartis AG
    Inventors: Daniel Ford, John Robert Porter, Michael Scott Visser, Naeem Yusuff
  • Imidazopyridine Derivatives as Modulators of TNF Activity
    Publication number: 20150203486
    Abstract: A series of imidazo[1,2-a]pyridine derivatives of formula (I), being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.
    Type: Application
    Filed: July 5, 2013
    Publication date: July 23, 2015
    Inventors: Jonathan Mark Bentley, Daniel Christopher Brookings, Julien Alistair Brown, Thomas Paul Cain, Praful Tulshi Chovatia, Anne Marie Foley, Ellen Olivia Gallimore, Laura Jane Gleave, Alexander Heifetz, Helen Tracey Horsley, Martin Clive Hutchings, Victoria Elizabeth Jackson, James Andrew Johnson, Craig Johnstone, Boris Kroeplien, Fabien Claude Lecomte, Deborah Leigh, Martin Alexander Lowe, James Madden, John Robert Porter, Joanna Rachel Quincey, Laura Claire Reed, James Thomas Reuberson, Anthony John Richardson, Sarah Emily Richardson, Matthew Duncan Selby, Michael Alan Shaw, Zhaoning Zhu
  • Imidazopyrazine Derivatives as Modulators of TNF Activity
    Publication number: 20150191482
    Abstract: A series of imidazo[1,2-?]pyrazine derivatives, being potent modulators of human TNF? activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorder; and oncological disorders.
    Type: Application
    Filed: July 5, 2013
    Publication date: July 9, 2015
    Inventors: Jonathan Mark Bentley, Daniel Christopher Brookings, Julien Alistair Brown, Thomas Paul Cain, Laura Jane Gleave, Alexander Heifetz, Victoria Elizabeth Jackson, Craig Johnstone, Deborah Leigh, James Madden, John Robert Porter, Matthew Duncan Selby, Zhaoning Zhu
  • TNF -Alpha Modulating Benzimidazoles
    Publication number: 20150152065
    Abstract: A series of benzimidazole derivatives, being potent modulators of human TNF? activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.
    Type: Application
    Filed: June 11, 2013
    Publication date: June 4, 2015
    Inventors: Daniel Christopher Brookings, Mark Daniel Calmiano, Ellen Olivia Gallimore, Helen Tracey Horsley, Martin Clive Hutchings, James Andrew Johnson, Boris Kroeplien, Fabien Claude Lecomte, Martin Alexander Lowe, Timothy John Norman, John Robert Porter, Joanna Rachel Quincey, James Thomas Reuberson, Matthew Duncan Selby, Michael Alan Shaw, Zhaoning Zhu, Anne Marie Foley
  • COMPOUNDS FOR INHIBITING THE INTERACTION OF BCL2 WITH BINDING PARTNERS
    Publication number: 20140357633
    Abstract: The present invention relates to compounds of formula I: in which R1, R2, R3 and R4 are as defined in the Summary of the Invention. Compounds of formula I are capable of disrupting the BCL-2 interations with proteins containing a BH3 domain. Disrupting this interaction can restore the anti-apoptotic function of BCL-2 in cancer cells and tumor tissue expressing BCL-2. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds in the treatment of cancerous diseases.
    Type: Application
    Filed: December 12, 2012
    Publication date: December 4, 2014
    Inventors: Daniel Ford, John Robert Porter, Michael Scott Visser, Naeem Yusuff
  • COMPOUNDS FOR INHIBITING THE INTERACTION OF BCL2 WITH BINDING PARTNERS
    Publication number: 20140350014
    Abstract: The present invention relates to compounds of formula I: in which R1, R2, R3 and R4 are as defined in the Summary of the Invention. Compounds of formula I are capable of disrupting the BCL-2 interations with proteins containing a BH3 domain. Disrupting this interaction can restore the anti-apoptotic function of BCL-2 in cancer cells and tumor tissue expressing BCL-2. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds in the treatment of cancerous diseases.
    Type: Application
    Filed: December 12, 2012
    Publication date: November 27, 2014
    Applicant: NOVARTIS AG
    Inventors: Daniel Ford, John Robert Porter, Michael Scott Visser, Naeem Yusuff
  • COMPOUNDS FOR INHIBITING THE INTERACTION OF BCL2 WITH BINDING PARTNERS
    Publication number: 20140343093
    Abstract: The present invention relates to compounds of formula I: in which R1, R2, R3 and R4 are as defined in the Summary of the Invention. Compounds of formula I are capable of disrupting the BCL-2 interations with proteins containing a BH3 domain. Disrupting this interaction can restore the anti-apoptotic function of BCL-2 in cancer cells and tumor tissue expressing BCL-2. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds in the treatment of cancerous diseases.
    Type: Application
    Filed: December 12, 2012
    Publication date: November 20, 2014
    Inventors: Daniel Ford, John Robert Porter, Michael Scott Visser, Naeem Yusuff
  • SYSTEM AND METHOD FOR OPERATING A DIESEL ENGINE
    Publication number: 20140327248
    Abstract: A power generating set includes an engine operable in response to a flow of fuel to produce a flow of exhaust gas. A generator is coupled to the engine and is operable in response to operation of the engine to produce a total electrical power, a primary load is electrically connected to the generator to receive a portion of the total electrical power, and a secondary load is selectively connected to the generator to receive a portion of the total electrical power. An insulated-gate bipolar transistor (IGBT) is positioned to selectively transition between a connected state and a disconnected state. The secondary load is connected to the generator when the IGBT is in the connected state and is disconnected from the generator when the IGBT is in the disconnected state.
    Type: Application
    Filed: May 2, 2014
    Publication date: November 6, 2014
    Applicant: CLARK EQUIPMENT COMPANY
    Inventors: John Thomas Gunn, Robert Porter Edwards, Barry Eugene Reavis
  • METHOD FOR SHARING A MEDIA COLLECTION IN A NETWORK ENVIRONMENT
    Publication number: 20140298406
    Abstract: In one aspect, the present disclosure provides for the accessing and playing of media files having differing associated rights such as non-DRM media files, purchased and downloaded media files, subscription download files such as tethered downloads, and subscription streamed DRM files. In one embodiment, the present disclosure provides a method and user interface for sharing a media collection among computing devices in communication via a network. In one embodiment, the disclosed method allows access and playback, from each computing device on a network, of all media files in a media collection, regardless of their associated rights.
    Type: Application
    Filed: November 27, 2013
    Publication date: October 2, 2014
    Applicant: Yahoo! Inc.
    Inventors: Ryan Eric King, David E. Brown, Robert Porter, Adam Korman, Manish Upendran, Kathleen Wilson